Routine lumbar puncture for the early diagnosis of Alzheimer's disease. Is it safe?

Frontiers in Aging Neuroscience

Volumn 6, Issue APR, 2014, Pages

  Menéndez González, Manuel ^a,b  

^a HOSPITAL ÁLVAREZ BUYLLA   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Alzheimer; CSF; dementia; feasibility studies; lumbar puncture; mild cognitive impairment; safety

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; HUMAN; LUMBAR PUNCTURE; LUMBAR PUNCTURE NEEDLE; MEDICAL PROCEDURES; MILD COGNITIVE IMPAIRMENT; NOTE; PATIENT ATTITUDE; PATIENT SAFETY; POSTDURAL PUNCTURE HEADACHE; VISUAL ANALOG SCALE;

EID: 84901377399     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00065     Document Type: Note

References (9)

1. Zafra, G., and Torrente-Orihuela, C. (2005). Llegará a ser la punción lumbar una prueba de rutina para el diagnóstico de la enfermedad de Alzheimer? Archivos de Medicina 1, 10.
2. Buchhave, P., Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O. (2012). Cerebrospinal fluid levels of ß-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch. Gen. Psychiatry 69, 98-106. doi: 10.1001/archgenpsychiatry.2011.155
3. Cummings, J. L. (2011). Biomarkers in Alzheimer's disease drug development. Alzheimers Dement. 7, e13-e44. doi: 10.1016/j.jalz.2010.06.004
4. Evans, R. W., Armon, C., Frohman, E. M., and Goodin, D. S. (2000). Assessment: prevention of post-lumbar puncture headaches: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 55, 909-914. doi: 10.1212/WNL.55.7.909
5. Galluzzi, S., Geroldi, C., Amicucci, G., Bocchio-Chiavetto, L., Bonetti, M., Bonvicini, C., et al. (2013). Translational outpatient memory clinic working group. Supporting evidence for using biomarkers in the diagnosis of MCI due to AD. J. Neurol. 260, 640-650. doi: 10.1007/s00415-012-6694-0
6. Lanari, A., and Parnetti, L. (2009). Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical setting. ScientificWorldJournal 9, 961-966. doi: 10.1100/tsw.2009.106
7. Peskind, E., Nordberg, A., Darreh-Shori, T., and Soininen, H. (2009). Safety of lumbar puncture procedures in patients with Alzheimer's disease. Curr. Alzheimer Res. 6, 290-292. doi: 10.2174/156720509788486509
8. van Rossum, I. A., Vos, S. J., Burns, L., Knol, D. L., Scheltens, P., Soininen, H., et al. (2012). Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology 79, 1809-1816. doi: 10.1212/WNL.0b013e3182704056
9. Wilner, A. N. (2010). Alzheimer's CSF Test: Useful or Useless? New York, NY: Medscape